Vera Alberto, Cecconi Alberto, Ximénez-Carrillo Álvaro, Ramos Carmen, Martínez-Vives Pablo, Lopez-Melgar Beatriz, Sanz-García Ancor, Ortega Guillermo, Aguirre Clara, Montes Álvaro, Vivancos José, Jiménez-Borreguero Luis Jesús, Alfonso Fernando
Cardiology Department, Hospital Universitario de La Princesa, IIS-IP, CIBER-CV, Universidad Autónoma de Madrid, c/Diego de León 62, 28006, Madrid, Spain.
Stroke Center, Neurology Department, Hospital Universitario de La Princesa, IIS-IP, Universidad Autónoma de Madrid, Madrid, Spain.
Heart Vessels. 2023 Jun;38(6):817-824. doi: 10.1007/s00380-023-02235-y. Epub 2023 Jan 25.
Diabetes mellitus is a highly prevalent and growing chronic disease that is associated with increased risk of recurrence among several stroke subtypes. However, evidence on the prognostic role of diabetes in the setting of cryptogenic stroke (CS) remains scarce.
From April 2019 to November 2021, we recruited prospectively 78 consecutive patients with CS. Patients were classified according to the presence of diabetes. Main outcome was the composite of stroke recurrence and death. Secondary outcome was stroke recurrence.
Mean age of the cohort was 78 ± 7.7 years and 18 patients (23%) had diabetes. After a median clinical follow-up of 23 months the incidence of stroke recurrence and mortality [HR 5.8 (95% CI 1.9-19), p = 0.002] and the incidence of stroke recurrence [HR 16.6 (95% CI 1.8-149), p = 0.012], were higher in patients with diabetes. After adjusting for potential confounders diabetes was identified as an independent predictor of stroke recurrence and death in patients with CS [HR 33.8 (95% CI 2.1-551), p = 0.013]. Other independent predictors of stroke recurrence and mortality were hypertension [HR 31.4 (95% CI 1.8-550), p = 0.018], NTproBNP [HR 1.002 (95% CI 1.001-1.004), p = 0.013] and chronic kidney disease (CKD) [HR 27.4 (95% CI 1.4-549) p = 0.03]. Furthermore, diabetes was an independent predictor of stroke recurrence [HR 103 (95% CI 1.3-8261), p = 0.038].
Diabetic patients with CS are at higher risk of stroke recurrence and death. Hypertension CKD and NTproBNP are also independent predictors of stroke recurrence and death after CS.
糖尿病是一种高度流行且日益增多的慢性病,与几种卒中亚型的复发风险增加相关。然而,关于糖尿病在隐源性卒中(CS)中的预后作用的证据仍然稀少。
从2019年4月至2021年11月,我们前瞻性地招募了78例连续的CS患者。根据是否患有糖尿病对患者进行分类。主要结局是卒中复发和死亡的复合结局。次要结局是卒中复发。
该队列的平均年龄为78±7.7岁,18例患者(23%)患有糖尿病。经过23个月的中位临床随访,糖尿病患者的卒中复发和死亡率[风险比(HR)5.8(95%置信区间[CI]1.9 - 19),p = 0.002]以及卒中复发率[HR 16.6(95% CI 1.8 - 149),p = 0.012]更高。在对潜在混杂因素进行调整后,糖尿病被确定为CS患者卒中复发和死亡的独立预测因素[HR 33.8(95% CI 2.1 - 551),p = 0.013]。卒中复发和死亡的其他独立预测因素包括高血压[HR 31.4(95% CI 1.8 - 550),p = 0.018]、N末端脑钠肽前体(NTproBNP)[HR 1.002(95% CI 1.001 - 1.004),p = 0.013]和慢性肾脏病(CKD)[HR 27.4(95% CI 1.4 - 549),p = 0.03]。此外,糖尿病是卒中复发的独立预测因素[HR 103(95% CI 1.3 - 8261),p = 0.038]。
CS糖尿病患者的卒中复发和死亡风险更高。高血压、CKD和NTproBNP也是CS后卒中复发和死亡的独立预测因素。